Adial Pharmaceuticals, Inc - Common Stock Share · US00688A2050 · ADIL (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Adial Pharmaceuticals, Inc - Common Stock

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

01.05.2026 20:00

Current Prices from Adial Pharmaceuticals, Inc - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	ADIL	USD	01.05.2026 20:00	1,55 USD	0,01 USD +0,65 %
IEX	ADIL	USD	01.05.2026 19:58	1,60 USD	0,06 USD +3,90 %

Share Float & Liquidity

Free Float 99,51 %

Shares Float 954.946,00

Shares Outstanding 959.644,00

Company Profile for Adial Pharmaceuticals, Inc - Common Stock Share

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.